Home » Topics » BioWorld Science

BioWorld Science
RSS

p21-controlled immunoclearance mechanism identified in senescent cells

Nov. 19, 2021

Researchers develop new model of heart failure with preserved ejection fraction

Nov. 19, 2021

Artizan and Biohaven begin therapeutic discovery and development program in Parkinson's

Nov. 19, 2021

A-2342: a highly potent, selective, orally available NTCP inhibitor

Nov. 19, 2021

Discovery of novel APJ receptor agonist with promising activity in acute hemodynamic rat model

Nov. 19, 2021

Bexson expands ketamine patch pump program into depression

Nov. 19, 2021

Biopolar Hongye (Nantong) Pharmaceutical synthesizes JAK2 inhibitors

Nov. 19, 2021

Chinese researchers synthesize new phosphodiesterase PDE4 inhibitors

Nov. 19, 2021

Beijing Tide Pharmaceutical identifies GTPase KRAS inhibitors

Nov. 19, 2021

Betta Pharmaceuticals patents new compounds for cancer

Nov. 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...